Luminogenic cytochrome P450 assays.

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• Cytochrome P450 (CYP) enzymes are crucial for drug metabolism.
• Accurate and efficient assays are needed for drug discovery and development.
• Existing methods like HPLC and radiochemical assays have limitations in speed, safety, and sensitivity.

Purpose of the Study:

• To introduce and evaluate novel luminogenic CYP assays utilizing firefly luciferase luminescence.
• To demonstrate the utility of these assays for detecting CYP enzyme activity, inhibition, and induction.
• To highlight the advantages of these assays over traditional methods for high-throughput screening.

Main Methods:

• Development and application of P450-Glo™ assays using luminogenic substrates.
• Testing of human CYP enzymes (e.g., CYP1A1, CYP3A4) with recombinant enzymes, liver microsomes, and cultured hepatocytes.
• Detection of dose-dependent CYP inhibition by test compounds.
• Measurement of CYP induction or inhibition in intact cultured hepatocytes using a nonlytic approach.

Main Results:

• The assays successfully measure activity and inhibition across a range of human CYP isoforms.
• Nonlytic assays allow for subsequent analysis of treated hepatocytes.
• Luminogenic CYP assays demonstrate superior speed, safety, sensitivity, and reduced interference compared to HPLC, radiochemical, and fluorogenic methods.

Conclusions:

• Luminogenic CYP assays are sensitive, robust, and homogeneous tools for early drug discovery.
• These assays facilitate high-throughput screening of drug candidates for CYP interactions.
• The technology offers significant advantages for CYP activity and inhibition assessment in various biological systems.